The GLP-1 Crackdown Is Here. Now What?

Your cheap semaglutide is gone. On April 1, the FDA published updated enforcement guidance that effectively ends the compounded GLP-1 era. No more $179/month telehealth semaglutide. No more B12 workarounds or salt form games. The shortage is resolved, the grace periods expired, and a federal court upheld the FDA's decision.

If your entire weight loss strategy depended on a compounded injectable, you need a new plan.

But here's the thing about that plan: it shouldn't have been built around a drug in the first place.

---

What Actually Happened

For three years, compounding pharmacies were legally allowed to produce generic versions of semaglutide and tirzepatide because Novo Nordisk and Eli Lilly couldn't keep up with demand. The drugs were on the FDA's official shortage list, which opened a legal window for compounders to fill the gap.

That window is now closed.

Both semaglutide and tirzepatide have been removed from the shortage list. The FDA's latest guidance makes the rules explicit: if your compounded product contains the same active ingredient, in a similar strength, given by the same route as an FDA-approved drug, it's an "essentially a copy." Even adding vitamin B12 doesn't change that classification. Even modifying the salt form (semaglutide sodium, semaglutide acetate) doesn't work. The FDA has stated these salt forms have "unknown safety and effectiveness" and there is "no lawful basis" for compounding them.

Brand-name Ozempic, Wegovy, and Mounjaro remain available. At $1,000 to $1,500 per month without insurance.

So millions of people who were managing their weight with affordable compounded GLP-1s are now priced out. And the clinics that built their entire business model around cheap semaglutide are scrambling.

---

The Question Nobody's Asking

Here's what gets lost in the pricing panic: why did you need semaglutide in the first place?

GLP-1 receptor agonists work. I'm not disputing that. They reduce appetite, slow gastric emptying, improve insulin sensitivity, and produce meaningful weight loss. The clinical data is strong. But they're treating a downstream effect. They're managing the symptom of metabolic dysfunction without asking what caused the dysfunction.

For a significant percentage of people struggling with unexplained weight gain, fatigue, brain fog, cold intolerance, and an inability to lose weight despite doing "everything right," the root cause is sitting in their thyroid gland. And nobody's checking.

---

The Thyroid Problem Hiding in Plain Sight

Before the 1940s, hypothyroidism was diagnosed based on signs, symptoms, and basal metabolic rate. The estimated prevalence was 30-40% of the American population. Then the protein-bound iodine (PBI) blood test came along and dropped that estimate to 5%. By the time PBI was shown to be only vaguely related to actual thyroid function, the 5% doctrine had already become gospel. Every test that followed was calibrated to it.

Ray Peat documented this history extensively: the diagnostic rules for hypothyroidism were set by a test that didn't work, and we've been living inside that mistake ever since.

Today, the American Thyroid Association estimates clinical hypothyroidism affects 5-12% of U.S. adults. When subclinical hypothyroidism is included (elevated TSH with technically "normal" free T4), the number climbs to 5-15%, with rates approaching 20% in older women. About 60% of those people have no idea anything is wrong (ATA, 2021).

Your thyroid controls your resting metabolic rate. When it underperforms, everything downstream suffers. Metabolism slows. Energy tanks. You gain weight without changing anything and exercise produces nothing. You sleep eight hours and wake up tired.

The standard medical response? "Your labs are normal." Because most doctors only test TSH, and "normal" on a lab range means you fall somewhere between the 2.5th and 97.5th percentile of the general population. An 8- to 10-fold variation is considered acceptable for TSH. For virtually any other biological measurement (sodium, calcium, glucose), a 10-20% deviation from the mean raises concern.

In my clinical experience, I've rarely seen someone with a TSH above 2.0 who was genuinely thriving. The "normal" range captures people who are functional. It doesn't capture people who are optimal.

Normal is not the same as optimal.

---

The Fluoride Connection

This is where it gets uncomfortable, because it involves something most Americans consume every single day.

Fluoride is a halide. It belongs to the same chemical family as iodine, chlorine, and bromine. These elements share similar atomic structures, which means they interact with the same biological systems.

Your thyroid gland concentrates iodine through a protein called the sodium-iodide symporter (NIS). This is the gateway. Iodine enters through the NIS, gets incorporated into thyroid hormones T3 and T4, and those hormones regulate your metabolism. Without adequate iodine uptake, thyroid hormone production drops.

Fluoride impairs this process through multiple pathways. It inhibits the sodium-potassium pump that NIS depends on to function, reducing the transporter's capacity to pull iodine into the thyroid cell. It upregulates inflammatory cytokines (TNF-alpha, TGF-beta, IL-6) that suppress NIS expression directly. The net effect is reduced iodine uptake, even when dietary iodine is adequate.

This isn't fringe science. Doctors in Europe and South America were using fluoride to suppress overactive thyroids in the same decade it was being added to American water supplies to prevent cavities (Galletti and Joyet, 1958, Journal of Clinical Endocrinology and Metabolism). The therapeutic use was eventually discontinued. The water additive was not.

A 2015 study in the Journal of Epidemiology and Community Health (Peckham et al.) found that populations in fluoridated areas of England had significantly higher rates of hypothyroidism compared to non-fluoridated areas. Practices in the fluoridated West Midlands were nearly twice as likely to report high hypothyroidism prevalence versus non-fluoridated Greater Manchester. A 2023 study from York University (Riddell et al., Science of the Total Environment) linked fluoride exposure during pregnancy to a 1.65x increased risk of hypothyroidism in pregnant women, with downstream effects on offspring cognitive development.

The disruption goes beyond iodine transport. Research in animal models shows fluoride also inhibits thyroid peroxidase (TPO), the enzyme responsible for incorporating iodine into thyroid hormones. And it appears to interfere with deiodinase enzymes, which convert the less active T4 into the more active T3 in peripheral tissues. Georgi Dinkov's extensive review of the thyroid literature puts it bluntly: "fluoride in tap water is one likely cause of hypothyroidism."

Every step of the process gets hit. Iodine can't get in efficiently. What does get in can't be fully activated. What gets activated can't always be converted to the form your cells actually use.

Now consider that most Americans are already iodine-insufficient. The RDA for iodine is 150 micrograms per day. In my practice, I consider that a floor, not a target. When iodine status is already marginal, fluoride's inhibitory effects hit harder. The iodine-deficiency interaction has been documented in animal research going back decades: fluoride is significantly more thyrotoxic when iodine is already low.

Fluoridated water in. Fluoridated foods in. Fluoride toothpaste twice a day. The iodine transporter is working against you before you've even had breakfast.

---

Connecting the Dots

Here's the pattern I see clinically.

Patient comes in. They've gained 20-40 pounds over the past few years. They eat reasonably well. They exercise. Nothing moves the scale. Their primary care doctor ran a TSH. It came back at 3.8 mIU/L. "Normal." No further investigation.

But when we run the full panel (TSH, free T3, free T4, reverse T3, TPO antibodies, thyroglobulin antibodies) and check iodine status, the picture changes. Free T3 is low-normal. Reverse T3 is elevated, meaning T4 is being shunted into the inactive form instead of the active one. TPO antibodies are positive. Iodine is insufficient.

Their thyroid is struggling. Not failing dramatically enough for a conventional diagnosis, but underperforming enough to tank their metabolism, their energy, and their ability to manage their weight.

And here's what makes this worse: many of these patients are also chronically dieting. Low calorie, low carb, intermittent fasting. They're doing it because they can't lose weight and they think the answer is eating less. But as Peat and Dinkov have documented extensively, caloric restriction and carbohydrate restriction directly suppress T4-to-T3 conversion and increase reverse T3. The dieting is making the thyroid problem worse. The weight loss stalls further. The patient restricts harder. It's a vicious cycle, and at no point does anyone check the thyroid properly.

These are the people who were buying compounded semaglutide. Their metabolism is genuinely compromised at the hormonal level. The drug helped them lose weight because their body couldn't do it on its own. That's the part nobody addressed. And now that the drug is gone or costs $1,200/month, they're stuck.

---

A Different Approach

I'm not suggesting anyone stop a prescribed GLP-1 without clinical guidance. What I'm suggesting is that if weight management is the goal, treating the root cause produces better, more sustainable outcomes than suppressing appetite with a weekly injection.

The testing matters more than most people realize. TSH alone doesn't tell you enough. You need free T3, free T4, reverse T3, and both TPO and thyroglobulin antibodies. That's the full picture, not just pituitary signaling. Then iodine status via a 24-hour urine loading test, because most people assume they're getting enough and they're not. Then halide exposure: fluoride from water and food, bromide from processed grain products and flame retardants, perchlorate from contaminated groundwater. You can't fix iodine uptake if you're still flooding the system with competing halides.

Once you have the data, the interventions are straightforward. If iodine is low, supplementation under clinical supervision (especially important in the presence of Hashimoto's, where iodine loading without selenium can flare autoimmunity). Selenium at 200mcg daily, which serves double duty: it's the cofactor for the deiodinase enzymes that convert T4 to T3, and it reduces TPO antibodies by 26-40% in Hashimoto's patients across multiple trials. Adequate carbohydrate intake, because your liver needs glucose to run T4-to-T3 conversion efficiently. Taurine, which Dinkov's research suggests can double T4-to-T3 conversion rates. Fluoride-specific water filtration (standard carbon filters don't remove fluoride; you need reverse osmosis or activated alumina). Retest in 8-12 weeks. Adjust based on what the numbers and the patient actually show.

The fix is not complicated. It just requires someone willing to look. Learn more about our approach to thyroid optimization and medical weight loss.

---

The Bigger Picture

The GLP-1 story is a case study in how modern medicine defaults to managing symptoms at scale. A drug gets developed. It works. An entire industry builds around distributing it as cheaply and widely as possible. The FDA steps in. Access disappears. Millions of patients are left with the same problem they started with, minus the pharmaceutical band-aid.

Meanwhile, the question that should have been asked from the beginning remains unanswered for most of them. Why can't I lose weight? Why am I exhausted? Why does everything I try fail?

For many people, the answer is sitting in their thyroid. A gland that's been quietly underperforming for years, suppressed by environmental halides, missed by inadequate testing, and ignored by a medical system that looks at a TSH of 3.8 and says "you're fine."

If you've been using compounded semaglutide and it worked for you, I genuinely understand the frustration of losing that option. But this is also a moment to get curious about what was happening underneath the drug. Your thyroid is worth investigating. Your iodine status is worth checking. The answers are often simpler and cheaper than another prescription. They just require someone willing to ask the right questions.